Cargando…

Employment status, productivity loss, and associated factors among people with multiple sclerosis

BACKGROUND: Multiple Sclerosis (MS) affects people in their most productive years of life. Consequently, MS can substantially affect employment and work-related outcomes. OBJECTIVES: This study characterizes productivity loss and employment status of people with multiple sclerosis (pwMS) and investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez Llorian, Elisabet, Zhang, Wei, Khakban, Amir, Michaux, Kristina, Patten, Scott, Traboulsee, Anthony, Oh, Jiwon, Kolind, Shannon, Prat, Alexandre, Tam, Roger, Lynd, Larry D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278386/ https://www.ncbi.nlm.nih.gov/pubmed/37060245 http://dx.doi.org/10.1177/13524585231164295

Ejemplares similares

Productivity loss among people with early multiple sclerosis: A Canadian study
por: Rodriguez Llorian, Elisabet, et al.
Publicado: (2022)

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design
por: Oh, Jiwon, et al.
Publicado: (2021)

Accounting for uncertainty in training data to improve machine learning performance in predicting new disease activity in early multiple sclerosis
por: Tayyab, Maryam, et al.
Publicado: (2023)

Quantitative neuroimaging measures of myelin in the healthy brain and in multiple sclerosis
por: O'Muircheartaigh, Jonathan, et al.
Publicado: (2019)

Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging
por: Kolind, Shannon, et al.
Publicado: (2023)

Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica
por: Manogaran, Praveena, et al.
Publicado: (2016)

Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression
por: Law, Marco TK, et al.
Publicado: (2019)

Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a
por: Kolind, Shannon, et al.
Publicado: (2022)

Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study
por: Khakban, Amir, et al.
Publicado: (2019)

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker
por: Kolind, Shannon, et al.
Publicado: (2015)

Deep learning of joint myelin and T1w MRI features in normal-appearing brain tissue to distinguish between multiple sclerosis patients and healthy controls
por: Yoo, Youngjin, et al.
Publicado: (2017)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis
por: Matthews, Lucy, et al.
Publicado: (2015)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Both Stationary and Dynamic Functional Interhemispheric Connectivity Are Strongly Associated With Performance on Cognitive Tests in Multiple Sclerosis
por: Lin, Sue-Jin, et al.
Publicado: (2020)

Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?
por: Lee, Lisa Eunyoung, et al.
Publicado: (2019)

Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis
por: Bansback*, Nick, et al.
Publicado: (2021)

Cortical morphology predicts placebo response in multiple sclerosis
por: Cherkasova, Mariya V., et al.
Publicado: (2022)

Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients
por: Bansback, Nick, et al.
Publicado: (2019)

Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder
por: Combes, Anna J.E., et al.
Publicado: (2017)

Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis
por: Lee, Lisa Eunyoung, et al.
Publicado: (2021)

Data fusion detects consistent relations between non-lesional white matter myelin, executive function, and clinical characteristics in multiple sclerosis
por: Baumeister, Tobias R., et al.
Publicado: (2019)

Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis()
por: Tam, Roger C., et al.
Publicado: (2012)

How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma
por: Khakban, Amir, et al.
Publicado: (2018)

Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS
por: Arnold, Douglas L, et al.
Publicado: (2022)

Myelin imaging in amyotrophic and primary lateral sclerosis
por: Kolind, Shannon, et al.
Publicado: (2013)

Data on medical technology: A new set of variables
por: Rodriguez Llorian, Elisabet, et al.
Publicado: (2020)

Self‐employment, sickness absence, and disability pension in multiple sclerosis
por: Machado, Alejandra, et al.
Publicado: (2022)

Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a
por: MacMillan, Erin L, et al.
Publicado: (2019)

Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis
por: Abel, Shawna, et al.
Publicado: (2020)

Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic
por: Jure Hunt, David, et al.
Publicado: (2020)

Comparison of employment among people with Multiple Sclerosis across Europe
por: Ellenberger, David, et al.
Publicado: (2022)

Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome
por: Johnson, P, et al.
Publicado: (2022)

Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis
por: Bonafede, Machaon, et al.
Publicado: (2020)

Comparison of multi echo T(2) relaxation and steady state approaches for myelin imaging in the central nervous system
por: Dvorak, Adam V., et al.
Publicado: (2021)

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis
por: Schneider, Raphael, et al.
Publicado: (2022)

An update of teriflunomide for treatment of multiple sclerosis
por: Oh, Jiwon, et al.
Publicado: (2013)

Rapid myelin water imaging for the assessment of cervical spinal cord myelin damage
por: Dvorak, Adam V., et al.
Publicado: (2019)

An atlas for human brain myelin content throughout the adult life span
por: Dvorak, Adam V., et al.
Publicado: (2021)

Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials
por: Traboulsee, A, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ed0savio0auchck0jnq0jrmg4v